CD47 and neoplasm: In a study with oesophageal cell carcinoma, treatment with CD47 blocking increased the expression of both CTLA‐4 and PD‐1.87 Correspondingly, the combination of CD47 blocking with CTLA‐4 mAb significantly inhibited mouse xenografted tumour growth compared to CD47 single treatment.103